Quratis

Quratis FCF Yield

The Free Cash Flow Yield of Quratis (348080.KQ) as of Oct 16, 2026 is -12.49 %. In the previous year, Free Cash Flow Yield was -11.00 % — a change of 13.53% (lower).

FCF Yield

-12.49 %

YoY

13.53%

Last updated:

Free Cash Flow Yield of Quratis is 2025 -12.49 % . Free Cash Flow Yield of Quratis was 2024 -11.00 % . It decreases by 13.53% lower compared to the previous year.

The Quratis FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2020
-29.37 KRW
Jan 1, 2021
-22.93 KRW
Jan 1, 2022
-12.66 KRW
Jan 1, 2023
-14.74 KRW
Jan 1, 2024
-11.00 KRW
Jan 1, 2025
-12.49 KRW
The Quratis FCF Yield history
YEARFCF YieldYoY
-12.49 %+13.53%
-11.00 %-25.37%
-14.74 %+16.44%
-12.66 %-44.79%
-22.93 %-21.93%
-29.37 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quratis Stock analysis

What does Quratis do? Quratis Inc is a biotechnology company based in Seoul, South Korea, operating within the Health Care sector. The company went public on June 15, 2023, with its stock listed under the ticker 348080.KQ and ISIN KR734808080003. Quratis focuses on research and development in the pharmaceutical industry, specifically developing medicine and pharmaceutical products. The company is involved in the manufacture and sale of vaccines and peptide nucleic acid complexes. It also provides Cell Penetrating Peptide (CPP) platform services. Quratis is engaged in the development and research of vaccines, including tuberculosis vaccines for adults and adolescents and COVID-19 vaccines. The company has 91 employees and maintains a website at http://quratis.com/. Quratis operates in the biotechnology industry, emphasizing innovation in vaccine development and pharmaceutical research. Its headquarters are located in Seoul, South Korea, and it is active in the development of novel therapeutic solutions for global health challenges. The company's activities span from research to commercialization, with a focus on advancing medical treatments through biotechnology. Quratis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quratis stock

Free Cash Flow Yield of Quratis is -12.49 % in 2025.

Free Cash Flow Yield of Quratis changed from -11.00 % to -12.49 %, representing a 13.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Quratis since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Quratis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Quratis

All Key Metrics — Quratis